Misplaced Pages

Heather Bresch: Difference between revisions

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
Browse history interactively← Previous editNext edit →Content deleted Content addedVisualWikitext
Revision as of 04:39, 13 May 2011 editOhconfucius (talk | contribs)Autopatrolled, Extended confirmed users, Pending changes reviewers328,947 editsm →References: +cat← Previous edit Revision as of 06:24, 13 May 2011 edit undoNomoskedasticity (talk | contribs)Extended confirmed users, Pending changes reviewers, Rollbackers21,755 edits rv deletion -- merger can be discussedNext edit →
Line 1: Line 1:
'''Heather Bresch''' is president of ], Inc., a ]-based ] corporation that describes itself as the third largest generic pharmaceutical company in the world.<ref></ref> Bresch was appointed to Mylan's Board of Directors in March of 2011.<ref>, ''Pittsburgh Business Times'', 1 March 2011</ref> She has been active in attempts to prevent brand-name pharmaceuticals from delaying the release of ] and appeared before a special ] committee on the issue in 2006<ref name=senate>, ''PR Newswire'', 20 July 2006, accessed 2008-04-24</ref><ref>, ''Observer-Reporter (Washington, PA)'', 21 July 2006, accessed on 2008-04-24</ref> and again in 2009.<ref>Brent Kendall, , ''Wall Street Journal'', 3 June 2009</ref> '''Heather Bresch''' is president of ], Inc., a ]-based ] corporation that describes itself as the third largest generic pharmaceutical company in the world.<ref></ref> Bresch was appointed to Mylan's Board of Directors in March of 2011.<ref>, ''Pittsburgh Business Times'', 1 March 2011</ref> She has been active in attempts to prevent brand-name pharmaceuticals from delaying the release of ] and appeared before a special ] committee on the issue in 2006<ref name=senate>, ''PR Newswire'', 20 July 2006, accessed 2008-04-24</ref><ref>, ''Observer-Reporter (Washington, PA)'', 21 July 2006, accessed on 2008-04-24</ref> and again in 2009.<ref>Brent Kendall, , ''Wall Street Journal'', 3 June 2009</ref> Bresch also testified before the Food & Drug Administration ("FDA") in September 2010 on the issue of generic drug user fees, proposing a new user fee structure that aims to generate more funding for the FDA and provide greater assurance for pharmaceutical product safety.<ref>http://www.fda.gov/downloads/Drugs/NewsEvents/UCM226845.pdf</ref>


⚫ Bresch, the daughter of ] U.S. Senator ], was a graduate student at ] until 1998. She was named one of the top women in the global pharmaceutical industry by FiercePharma in 2009.<ref>, ''FiercePharma'' 12 Oct. 2009</ref> In 2007, the university awarded her an ] despite her having completed only 22 of the required 48 credits. Following release of a report commissioned by the university (and written by a panel of faculty members from WVU and other universities), the university announced in April 2008 that it would rescind Bresch's degree,<ref name=postgazette>Len Boselovic and Patricia Sabatini, "", ''Pittsburgh Post-Gazette'', 24 April 2008, accessed 2008-04-24</ref> and WVU's provost announced his resignation from that administrative post (he will remain on the faculty).<ref name=nyt0804>, ''New York Times'', 28 April 2008, accessed 2008-04-28</ref> On June 6, 2008, WVU President ] resigned in the wake of the scandal.<ref>, ''MSNBC.com'' 6 June 2008, accessed 2008-06-06</ref>
== Biography ==
Bresch, the daughter of ] U.S. Senator ], was a graduate student at ] until 1998. She was named one of the top women in the global pharmaceutical industry by FiercePharma in 2009.<ref>, ''FiercePharma'' 12 Oct. 2009</ref> On October 2, 2007 Bresch was promoted to chief operating officer at Mylan.<ref name="Mystery">{{cite news
| last = Sabatini
| first = Patricia
| coauthors = Len Boselovi
| title = MBA mystery in Morgantown
| work =
| pages =
| language =
| publisher = ]
| date = 2007-12-21
| url = http://www.post-gazette.com/pg/07355/843469-28.stm
| accessdate = }}
</ref>


The university initially stated that it had awarded the degree after correcting a "records error."<ref name=dailymail>Jake Stump, "," ''Charleston Daily Mail'', 28 December 2007, accessed 2008-04-24</ref> Bresch claimed in April 2008 that she had arranged with the WVU Business School to have her "work experience" substitute for the outstanding coursework<ref name=cnn>, ''] Money'', 10 April 2008, retrieved 2008-04-24</ref> - a claim reportedly denied by the then-head of the business school and rejected by the panel.<ref name=postgazette/>
⚫ The '']'' contacted WVU seeking to confirm Bresch's academic credentials, including her EMBA degree.<ref name="Mystery" /> The enquiry exposed that she was awarded the degree despite her having completed only 22 of the required 48 credits inconsistencies. The ] resulted in the rescission of the MBA degree,<ref name=postgazette>Len Boselovic and Patricia Sabatini, "", ''Pittsburgh Post-Gazette'', 24 April 2008, accessed 2008-04-24</ref> and resignation of WVU's provost from that administrative post.<ref name=nyt0804>, ''New York Times'', 28 April 2008, accessed 2008-04-28</ref> On June 6, 2008, WVU President ], a former consultant and lobbyist for Mylan<ref name=nyt>Ian Urbina, "", ''New York Times'', 22 January 2008, accessed 2008-04-24</ref> and "a family friend and former business associate of Bresch",<ref name=postgazette/> also resigned as a result.<ref>, ''MSNBC.com'' 6 June 2008, accessed 2008-06-06</ref>


The ''Pittsburgh Post-Gazette'' characterized the as criticising the university administration for having made "a 'seriously flawed' decision fraught with favoritism" in awarding Bresch the degree; ], WVU President at the time, was reported to be "a family friend and former business associate of Bresch"<ref name=postgazette/> and a former consultant and lobbyist for Mylan.<ref name=nyt>Ian Urbina, "", ''New York Times'', 22 January 2008, accessed 2008-04-24</ref>
⚫ Bresch maintained that she "did what was required to earn her degree."<ref name=nyt2>Ian Urbina, , ''New York Times'', 25 April 2008, accessed 2008-04-25</ref> After WVU announced in February 2009 that it would not rescind other degrees where students' records contained irregularities, Bresch wrote to the university demanding an explanation for what differentiated her situation from the others.<ref>Vicki Smith, , ''AP'', 7 February 2009</ref>


⚫ According to the ''New York Times'', Bresch said in a statement that she "continues to believe she did what was required to earn her degree."<ref name=nyt2>Ian Urbina, , ''New York Times'', 25 April 2008, accessed 2008-04-25</ref> After WVU announced in February 2009 that it would not rescind other degrees where students' records contained irregularities, Bresch wrote to the university demanding an explanation for what differentiated her situation from the others.<ref>Vicki Smith, , ''AP'', 7 February 2009</ref>
⚫ ==See also==


In the 2008 election campaign, Manchin challenger ] attempted to exploit the Bresch affair by offering "University of Mojo" diplomas, implying that Manchin was implicated in the attempt to grant his daughter an unearned degree. The Manchin campaign maintained that the governor had not been involved in the affair.<ref>Phil Kabler, , ''The Charleston Gazette'', 24 September 2008</ref>

⚫ ==See also==
]


==References== ==References==
Line 37: Line 28:
{{DEFAULTSORT:Bresch, Heather}} {{DEFAULTSORT:Bresch, Heather}}
] ]
]
] ]
] ]

Revision as of 06:24, 13 May 2011

Heather Bresch is president of Mylan, Inc., a Pittsburgh-based pharmaceutical corporation that describes itself as the third largest generic pharmaceutical company in the world. Bresch was appointed to Mylan's Board of Directors in March of 2011. She has been active in attempts to prevent brand-name pharmaceuticals from delaying the release of generic drugs and appeared before a special United States Senate committee on the issue in 2006 and again in 2009. Bresch also testified before the Food & Drug Administration ("FDA") in September 2010 on the issue of generic drug user fees, proposing a new user fee structure that aims to generate more funding for the FDA and provide greater assurance for pharmaceutical product safety.

Bresch, the daughter of West Virginia U.S. Senator Joe Manchin, was a graduate student at West Virginia University until 1998. She was named one of the top women in the global pharmaceutical industry by FiercePharma in 2009. In 2007, the university awarded her an M.B.A. despite her having completed only 22 of the required 48 credits. Following release of a report commissioned by the university (and written by a panel of faculty members from WVU and other universities), the university announced in April 2008 that it would rescind Bresch's degree, and WVU's provost announced his resignation from that administrative post (he will remain on the faculty). On June 6, 2008, WVU President Michael Garrison resigned in the wake of the scandal.

The university initially stated that it had awarded the degree after correcting a "records error." Bresch claimed in April 2008 that she had arranged with the WVU Business School to have her "work experience" substitute for the outstanding coursework - a claim reportedly denied by the then-head of the business school and rejected by the panel.

The Pittsburgh Post-Gazette characterized the panel's report as criticising the university administration for having made "a 'seriously flawed' decision fraught with favoritism" in awarding Bresch the degree; Michael Garrison, WVU President at the time, was reported to be "a family friend and former business associate of Bresch" and a former consultant and lobbyist for Mylan.

According to the New York Times, Bresch said in a statement that she "continues to believe she did what was required to earn her degree." After WVU announced in February 2009 that it would not rescind other degrees where students' records contained irregularities, Bresch wrote to the university demanding an explanation for what differentiated her situation from the others.

In the 2008 election campaign, Manchin challenger Russ Weeks attempted to exploit the Bresch affair by offering "University of Mojo" diplomas, implying that Manchin was implicated in the attempt to grant his daughter an unearned degree. The Manchin campaign maintained that the governor had not been involved in the affair.

See also

Heather Bresch M.B.A. controversy

References

  1. Mylan Inc. home page
  2. “Robert Cindrich, Heather Bresch named to Mylan board”, Pittsburgh Business Times, 1 March 2011
  3. "Mylan Calls for End to Abusive Practices That Delay Access to Affordable Pharmaceuticals", PR Newswire, 20 July 2006, accessed 2008-04-24
  4. "Mylan testifies before Senate special committee on aging", Observer-Reporter (Washington, PA), 21 July 2006, accessed on 2008-04-24
  5. Brent Kendall, "Lawmakers, Drug Makers Spar Over Patent Settlements", Wall Street Journal, 3 June 2009
  6. http://www.fda.gov/downloads/Drugs/NewsEvents/UCM226845.pdf
  7. "Heather Bresch - Top 15 Women in Pharma”, FiercePharma 12 Oct. 2009
  8. ^ Len Boselovic and Patricia Sabatini, "University revokes degree after scathing report on M.B.A. awarded to Bresch", Pittsburgh Post-Gazette, 24 April 2008, accessed 2008-04-24
  9. "Provost Quits Over Degree to Governor’s Child", New York Times, 28 April 2008, accessed 2008-04-28
  10. "College president to quit over degree scandal", MSNBC.com 6 June 2008, accessed 2008-06-06
  11. Jake Stump, "Official says controversy of Heather Bresch's WVU degree calls for investigation," Charleston Daily Mail, 28 December 2007, accessed 2008-04-24
  12. "Mylan Chairman Defends COO", CNN Money, 10 April 2008, retrieved 2008-04-24
  13. Ian Urbina, "University Investigates Whether Governor’s Daughter Earned Degree", New York Times, 22 January 2008, accessed 2008-04-24
  14. Ian Urbina, "Criticism for Degree to Governor’s Daughter", New York Times, 25 April 2008, accessed 2008-04-25
  15. Vicki Smith, "Governor's daughter seeks answer on revoked degree", AP, 7 February 2009
  16. Phil Kabler, "'Mojo' diplomas haven't been big earners", The Charleston Gazette, 24 September 2008

Template:Persondata

Categories: